Retirement Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$271 Hold
1
﹤0.01% 788
2023
Q4
$236 Hold
1
﹤0.01% 782
2023
Q3
$196 Hold
1
﹤0.01% 733
2023
Q2
$210 Hold
1
﹤0.01% 766
2023
Q1
$0 Hold
1
﹤0.01% 695
2022
Q4
$0 Hold
1
﹤0.01% 650
2022
Q3
$0 Hold
1
﹤0.01% 548
2022
Q2
$0 Hold
1
﹤0.01% 752
2022
Q1
$0 Buy
+1
New +$308 ﹤0.01% 752

Other funds holding CRL

Retirement Group's CRL Position: Q1 2024 in Review

Retirement Group held its Charles River Laboratories (CRL) position steady in Q1 2024 at 1 share worth $271. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Retirement Group first reported a position in CRL in Q1 2022 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Retirement Group held 1 share of Charles River Laboratories worth $271 as of Q1 2024.
  • Retirement Group left its Charles River Laboratories share count unchanged in Q1 2024.
  • Charles River Laboratories made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #788 holding.
  • Retirement Group first reported a position in Charles River Laboratories in Q1 2022 and has held it in 9 quarters since.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.